Results 211 to 220 of about 338,020 (352)

Usefulness of serum lipase for early diagnosis of post-endoscopic retrograde cholangiopancreatography pancreatitis

open access: hybrid, 2019
Masayoshi Tadehara   +11 more
openalex   +2 more sources

Genomic Insights into Lipid Dependency in Atypical Strains of Malassezia pachydermatis. [PDF]

open access: yesMycopathologia
Díaz L   +4 more
europepmc   +1 more source

A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity [PDF]

open access: hybrid, 2002
Zhiguang Su   +7 more
openalex   +1 more source

Transannular O‐Heterocyclization Reactions of Cyclododeca‐1,5,9‐triene Derivatives: A New Concept for the Preparation of Key Intermediates for Total Syntheses of Annonaceous Acetogenins

open access: yesHelvetica Chimica Acta, EarlyView.
Four stereogenic centers are formed diastereoselectively in one step from a cyclic (E,E)‐1,5‐diene system using an electrophilic addition reaction. Subsequent ozonolytic cleavage of the intact Z‐double bond, followed by intramolecular nucleophilic substitution, yields an octahydroterfurandione with a threo,cis,threo configuration, an arrangement found ...
Holger Schimanski   +6 more
wiley   +1 more source

Mechanisms of spinal glial activation in chemotherapy‐induced peripheral neuropathy: Focus on microglia and astrocytes

open access: yesIbrain, EarlyView.
Chemotherapy‐induced peripheral neuropathy (CIPN) remains a major clinical challenge, with central sensitization considered an important pathological mechanism in its occurrence and persistence. This review focuses on spinal astrocytes and microglia, systematically summarizing the pathological mechanisms of spinal glial cells involved in CIPN caused by
Long Gu, Song Cao, Yonghuai Feng
wiley   +1 more source

Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk criteria—A multi‐center retrospective analysis on behalf of the GUARDIANS group

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel   +21 more
wiley   +1 more source

Pharmacological Studies on Microbial Lipase

open access: diamond, 1964
Haruo Itô   +2 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy